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Author reply to comments posted by Zaki SA ,  J Vector Borne Dis, March 2009; 46(1): 83
Sir,
Zaki SA has pointed out a very valuable point of
rarity of thrombocytopenia in vivax malaria1.  How-
ever, thrombocytopenia has been found in 3.6% of
adult patients with P. vivax from India2 and in 2004
during the rainy season, we had six children who pre-
sented with fever and thrombocytopenia due to vivax
malaria3. Thrombocytopenia seen in complicated
falciparum malaria is due to disseminated intravas-
cular coagulation along with platelet endothelial
activation but the one seen in uncomplicated malaria
like  P. vivax has multifactorial etiology. Few
postulated mechanisms are macrophage activation
leading to platelet destruction4, increased levels of
cytokines5, immunological destruction due to
antiplatelet IgG6, oxidative stress7, shortened plate-
let life span in peripheral blood and sequestration in
nonsplenic areas8 and partly due to pseudothrombo-
cytopenia due to clumping of platelets9.
World Health Organization (WHO) has found that
severe vivax malaria manifestations have cerebral
malaria, severe anaemia, severe thrombocytopenia
and pancytopenia, jaundice, spleen rupture, acute
renal failure and acute respiratory distress syn-
drome10. However, the Korean study that was refer-
enced by WHO has found that chloroquine still
remains the therapy of vivax malaria with thromb-
ocytopenia. The Korean study done on 101 patients
found severe thrombocytopenia with platelet counts
< 60,000/μl in 29.6% of patients and all patients re-
sponded promptly to chloroquine therapy11. In the
case report by Makkar et al12, severe thrombocytope-
nia was seen in an adult with vivax malaria who also
had bleeding manifestations and was treated with
quinine directly without a trial of chloroquine. Thus
presence of isolated thrombocytopenia without any
other clinical manifestations of severe malaria may
still respond to chloroquine.
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